Elsevier

Human Pathology

Volume 28, Issue 5, May 1997, Pages 580-587
Human Pathology

Original contribution
Pathological and immunophenotypic features of adult non-Hodgkin's lymphomas by age group

https://doi.org/10.1016/S0046-8177(97)90080-0Get rights and content

Abstract

To elucidate age-related differences in non-Hodgkin's lymphoma (NHL), the authors evaluated 950 consecutive, human inununodeficiency virus—negative patients (age range, 15 to 96 years) observed between July 1988 and June 1995 in the same Italian cancer institute. Patients were grouped into six age groups and cross-tabulated by Working Formulation (WF) categories and other newly recognized entities according to the Revised European American Lymphoma (REAL) classification, cell immunophenotype, and nodal or extranodal location. There was a tendency of the low-grade category to increase with increasing age (16.8% in the age group 15 to 34 years to 32.4% in the age group 65 to 74 years), although a subsequent decline was seen at age 75 years or older (23.2%). Also the intermediate-grade category was more frequent in the elderly (46.6% and 49.4% at 65 to 74 years and at 75 years or older, respectively). High-grade category showed compared with low and intermediate grade ones, a significant downward trend with age (X2 for trend = 25.31; P < .001), interrupted in only the oldest age group. The relative excess of low-grade NHL in patients older than 55 years of age was accounted for by the high proportion of small lymphocytic lymphomas, which, however, somewhat declined at age 75 years or older. Conversely, the relative excess of high-grade NHL below age 35 years chiefly derived from the high percentage (28.4%) of CD30-positive anaplastic large cell lymphomas. B- and T-cell lymphomas accounted for 85.9% and 9.0% of all cases, respectively. B- and T- and non-B, nonT—cell and histiocytic NHL accounted for the remaining 5.1%. A highly significant trend of increase in the proportion of B-cell lymphomas with age increase was noted (X2 for trend = 21.90; P < .001), chiefly attributable to the excess of T-cell (15.1%) and undetermined phenotype (18.6%) in patients younger than 35 years of age. Extranodal location was not significantly related to age groups. Thus, the present study showed some interesting differences in NHL morphology and cell phenotype according to age, avoiding, at the same time, the arbitrariness of patients' dichotomization into elderly and nonelderly.

References (34)

  • NL Eby et al.

    Increasing incidence of primary brain lymphoma in the US

    Cancer

    (1988)
  • SE Jones et al.

    Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases

    Cancer

    (1973)
  • AS Patchefsky et al.

    Non-Hodgkin's lymphomas: A clinicopathologic study of 293 cases

    Cancer

    (1974)
  • BN Nathwani et al.

    Non-Hodgkin's lymphomas: A clinicopathologic study comparing two classifications

    Cancer

    (1978)
  • T Anderson et al.

    Malignant lymphoma. I. The histology and staging of 473 patients at the National Cancer Institute

    Cancer

    (1982)
  • A Carbone et al.

    Non-Hodgkin's lymphoma in the elderly: A retrospective clinicopathologic study of 50 patients

    Cancer

    (1986)
  • L Elias

    Differences in age and sex distribution among patients with non-Hodgkin's lymphoma

    Cancer

    (1979)
  • Cited by (13)

    • Hematologic malignancies in pregnancy

      2005, Obstetrics and Gynecology Clinics of North America
    • Cancer in Pregnancy

      2010, de Swiet's Medical Disorders in Obstetric Practice: Fifth Edition
    View all citing articles on Scopus

    Supported in part by Ministero della Sanita, Ricerca Finalizzata I.R.C.C.S., Rome, Italy, and by the Associazione Italiana per la Ricerca sul Cancro, Milan, Italy.

    View full text